Home Chronic Diseases Tags

View the Latest: Chronic Diseases

Filter

List Grid

11 - 20 of 61 Results

  • State Reported Efforts to Address Health Disparities: A 50 State Review

    Issue Brief

    This analysis focuses on current state efforts, many of which were implemented during or after 2020, to address health disparities and advance health equity based on a review of publicly available materials from all 50 states and DC. In addition, case study interviews were conducted with 14 stakeholders in three states (California, North Dakota, and Michigan) to increase understanding of the factors contributing to success of these state initiatives, lessons learned, and potential implications for other states.

  • Make American Health Care Affordable Again

    Perspective

    In this JAMA Health Forum column, Larry Levitt highlights how the Make America Healthy Again agenda aimed at chronic disease does little to address the affordability of health care and that efforts to lower federal spending on health care may worsen the problem, raising out-of-pocket costs for many people with Medicaid and Affordable Care Act…

  • Utilization of Health Care Services by Medicaid Expansion Status

    Issue Brief

    Some critics of Medicaid expansion have argued that expansion diverts resources away from other groups of Medicaid enrollees, including people with disabilities and children, and that expansion enrollees are “able-bodied” implying they have minimal health care needs. However, data show that expansion states spend more per enrollee overall and on each eligibility group than non-expansion states and that nearly half of expansion enrollees have a chronic condition. This data note analyzes 2021 Medicaid claims data to compare utilization of health care services among Medicaid expansion enrollees with other Medicaid enrollees in expansion states and to compare utilization of health care services among adult Medicaid enrollees living in expansion and non-expansion states.

  • FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries

    Issue Brief

    The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen's new FDA-approved Alzheimer's drug, which will cost $56,000 per year.

  • Loneliness and Social Isolation in the United States, the United Kingdom, and Japan: An International Survey

    Report

    To understand more about how people view the issue of loneliness and social isolation, the Kaiser Family Foundation, in partnership with The Economist, conducted a cross-country survey of adults in the United States, the United Kingdom, and Japan. The survey included additional interviews with individuals who report always or often feeling lonely, left out, isolated or that they lack companionship to better understand the personal characteristics and life circumstances associated with these feelings, the reported causes of loneliness, and how people are coping. More than a fifth of adults in the United States and the United Kingdom as well as one in ten adults in Japan say they often or always feel lonely, feel that they lack companionship, feel left out, or feel isolated from others, and many of them say their loneliness has had a negative impact on various aspects of their life. About six in ten say there is a specific cause of their loneliness, and they are also more likely to report experiencing negative life events in the past two years, such as a negative change in financial status. Those reporting loneliness in each country report having fewer confidants than others and two-thirds or more say they have just a few or no relatives or friends living nearby who they can rely on for support. Many in the U.S. and U.K. view the increased use of technology as a major reason why people are lonely or socially isolated, whereas fewer people in Japan say the same. But, for those experiencing loneliness or social isolation personally, they are divided as to whether they think social media makes their feelings of loneliness better or worse.

  • Public Opinion on Chronic Illness in America

    Feature

    The April 2018 Kaiser Health Tracking Poll finds six in ten say they or someone in their immediate family have a chronic health condition that requires ongoing medical treatment, and a third of those dealing with a chronic condition requiring ongoing medical care say they or their household have had problems paying medical bills in the past 12 months. This poll finding also looks at how the public views policies aimed at preventing chronic disease in America.

  • The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019

    Issue Brief

    Medicare Part D has helped to make prescription drugs more affordable for people with Medicare, yet many beneficiaries continue to face high out-of-pocket costs for their medications. Specialty tier drugs are a particular concern for Part D enrollees in this context. This analysis draws on data from Medicare’s Plan Finder website to calculate expected annual 2019 out-of-pocket costs for 30 specialty tier drugs used to treat four health conditions—cancer, hepatitis C, multiple sclerosis, and rheumatoid arthritis.